Literature DB >> 6975716

Decline, in aging mice, of the anti-2,4,6-trinitrophenyl (TNP) cytotoxic T cell response attributable to loss of Lyt-2-, interleukin 2-producing helper cell function.

R A Miller, O Stutman.   

Abstract

The in vitro generation of cytotoxic T lymphocytes (CTL) specific for 2,4,6-trinitrophenyl (TNP)-modified syngeneic spleen cells is found to be almost invariably depressed in apparently healthy 18-month-old mice of the long-lived (BALB/c x C57BL/6)F1 hybrid strain. Studies of CTL production from Lyt-2+ thymus cells have suggested that pre-killer cells may require, for maturation into effectors, the presence of a soluble helper factor, interleukin 2 (IL2), produced by Lyt-2- cells which are themselves devoid of pre-CTL activity. We have therefore developed a petri-dish adherence technique for separating spleen cells into Lyt-2+ and Lyt-2- populations in order to test for helper and pre-killer activity independently. Pre-CTL function is measured by stimulating Lyt-2+ cells in the presence of exogenous IL2. Helper cell activity is tested by adding Lyt-2- cells to "indicator" populations of Lyt-2+ pre-CTL. Estimation of IL2 levels in medium conditioned by unfractionated, TNP-self-stimulated splenocytes provides a second measurement of helper cell function. Mice 18 months of age, when compared to 4 month-old controls, are found to retain nearly all of their pre-CTL activity, but to have lost sufficient helper cell activity to account for the decline in unseparated spleen cell cultures. Older mice also produce lower IL2 levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975716     DOI: 10.1002/eji.1830111004

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice.

Authors:  Amir A Sadighi Akha; Scott B Berger; Richard A Miller
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

2.  Two separate defects affecting true naive or virtual memory T cell precursors combine to reduce naive T cell responses with aging.

Authors:  Kristin R Renkema; Gang Li; Angela Wu; Megan J Smithey; Janko Nikolich-Žugich
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

Review 3.  The effect of aging on host defences. Implications for therapy.

Authors:  A Scordamaglia; G Ciprandi; F Indiveri; G W Canonica
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

4.  Regulation of cellular immune responses by selenium.

Authors:  L Kiremidjian-Schumacher; M Roy; H I Wishe; M W Cohen; G Stotzky
Journal:  Biol Trace Elem Res       Date:  1992 Apr-Jun       Impact factor: 3.738

5.  Interleukin-2-induced activation of natural killer activity in spleen cells from old and young mice.

Authors:  R K Saxena; Q B Saxena; W H Adler
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

6.  Functional consequences of perceived interleukin deficiencies? Analysis employing NZB x C58 recombinant inbred mice.

Authors:  M H Bocchieri; J B Smith; J B Smith; M J Staruch; D D Wood
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

7.  Influence of age on the production and regulation of interleukin-1 in mice.

Authors:  T Inamizu; M P Chang; T Makinodan
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

8.  Aging and antimicrobial immunity. Lowered efficiency of protective T cells as a contributing factor for the decreased resistance of senescent mice to listeriosis.

Authors:  P J Patel
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

9.  Deficiency in suppressor T cell activity in aged animals. Reconstitution of this activity by interleukin 2.

Authors:  M L Thoman; W O Weigle
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Helper cells in the autologous mixed lymphocyte reaction. III. Production of helper factor(s) distinct from interleukin 2.

Authors:  J A Wolos; J B Smith
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.